This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2022, including also biosimilars. The generic share in the pharmaceutical industry's market sales in Denmark stood at 33 percent. The market share of generics is higher in newer EU member states due to lower levels of intellectual property protection.
Market share of generics and biosimilars in selected European countries in 2022
EFPIA: European Federation of Pharmaceutical Industries and Associations Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, Ireland, Hungary, Slovenia, U.K.: share of generics and biosimilars in pharmacy market sales. Austria, Belgium, France, Germany, Greece, Italy, Luxembourg, Netherlands, Portugal, Spain: share of generics and biosimilars in reimbursable pharmacy market sales. Latvia, Lithuania, Norway, Poland, Romania, Russia, Serbia, Slovakia, Sweden, Switzerland, Turkey: share of generics and biosimilars in total market sales. Ireland, Latvia, Lithuania, Russia: 2021 data; Cyprus, Iceland, Malta: data not available. France: data relate only to those active substances listed on the official list of medicines. ‘Generics’ are defined as medicines based on active substances that are out of patent and which are marketed under different names from that of the original branded medicines.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EFPIA. (June 24, 2024). Market share of generics and biosimilars in selected European countries in 2022 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/
EFPIA. "Market share of generics and biosimilars in selected European countries in 2022." Chart. June 24, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/
EFPIA. (2024). Market share of generics and biosimilars in selected European countries in 2022. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/
EFPIA. "Market Share of Generics and Biosimilars in Selected European Countries in 2022." Statista, Statista Inc., 24 Jun 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/
EFPIA, Market share of generics and biosimilars in selected European countries in 2022 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/ (last visited November 10, 2024)
Market share of generics and biosimilars in selected European countries in 2022 [Graph], EFPIA, June 24, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/316079/european-pharmaceutical-market-generics-share-by-country/
